Emergency treatment of asthma

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 1, 1996, Pages 66-74

  Peters, Jay I ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; TERBUTALINE; THEOPHYLLINE;

ACUTE DISEASE; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; ASTHMA; EMERGENCY; HOSPITAL ADMISSION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE; OXYGEN THERAPY; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; AIRWAY OBSTRUCTION; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; EMERGENCIES; EPINEPHRINE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTENSIVE CARE; OXYGEN INHALATION THERAPY; PATIENT ADMISSION; RESPIRATION, ARTIFICIAL; TERBUTALINE; THEOPHYLLINE; TREATMENT FAILURE;

EID: 0029677954     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Lowenthal M, Patterson R, Greenberger PA, Grammer LC: The application of an asthma severity index in patients with potentially fatal asthma. Chest 1993, 104:1329-1331.
2. Li D, German D, Lulla S, Thomas RG, Wilson SR: Prospective study of hospitalization for asthma: a preliminary risk factor model. Am J Respir Crit Care Med 1995, 151:647-655.
3. Kallenbach JM, Frankel AH, Lapinsky SE, Thornton AS, Blott JA, Smith C, Feldman C, Zwi S: Determinants of near fatality in acute severe asthma. Am J Med 1993, 95:265-272.
4. Kikuchi Y, Okabe S, Tamura G, Hida W, Homma M, Shirato K, Takishima T: Chemosensitivlty and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994, 330:1329-1334. Reviews physiologic defects in near-fatal asthma.
5. Brenner BE, Abraham E, Simon RR: Position and diaphoresis in acute asthma. Am J Med 1983, 74:1005-1009.
6. McFadden ER Jr: Management of patients with acute asthma: what do we know? What do we need to know? Ann Allergy 1994, 72:385-389. Excellent brief overview of controversial aspects of therapy in acute asthma.
7. Corbridge TC, Hall JB: The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995, 151:1296-1316. Most extensive overview of status asthmaticus, with over 200 references summarizing the recent literature.
8. Sly PD, Cahill P, Willet K, Burton P: Accuracy of mini peak flow meters In indicating changes in lung function in children with asthma. BMJ 1994, 308:572-574.
9. National Heart, Lung, and Blood Institute: National Asthma Education Program, Expert Panel Report: guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991, 88:425-433.
10. Mountain RD, Sahn SA: Clinical features and outcome in patients with acute asthma presenting with hypercapnia. Am Rev Respir Dis 1988, 138:535-539.
11. Mountain RD, Heffner JE, Brackett NC, Sahn SA: Acid-base disturbances in acute asthma. Chest 1990, 98:651-655.
12. Peters JI, Rossrucker J: Current concepts in managing status asthmaticus. J Respir Dis 1992, 13:829-849.
13. Loffert DT, Ikle D, Nelson HS: A comparison of commercial jet nebulizers. Chest 1994, 106:1788-1793.
14. Toogood JH, Jennings BH, Baskerville JC: Aerosol corticosteroids. In Bronchial Asthma: Mechanisms and Therapeutics, edn 3. Edited by Weiss EB, Stein M. Boston: Little, Brown & Co.; 1993:818-841.
15. Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L: Emergency department treatment of severe asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993, 103:665-672.
16. Turner JR, Corkery KJ, Eckman D, Gelb AM, Lipavsky A, Sheppard D: Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest 1988, 93:476-481.
17. Newhouse M: Aerosol generation and delivery systems for pulmonary drug targeting: principles and applications. Ontario Thorac Rev 1993, 5:1-5.
18. Chatila W, Hall JB, Manthous CA: Treatment of bronchospasm by metered-dose-inhaler albuterol via spacer in mechanically ventilated patients [abstract]. Am J Respir Crit Care Med 1994, 149:A190.
19. Kamada AK: Therapeutic controversies in the treatment of asthma. Ann Pharmacother 1994, 28:904-914. Excellent discussion of controversial issues in the treatment of asthma with extensive review of literature relating to these issues.
20. Appel D, Karpel JP, Sherman M: Epinephrine improves expiratory airflow rates in patients with asthma who do not respond to Inhaled metaproterenol sulfate. J Allergy Clin Immunol 1989, 84:90-98.
21. Amory DW, Bumham SC, Cheney FW Jr: Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutallne in patients with reversible airway obstruction. Chest 1975, 67:279-286.
22. Rowe BH, Keller JL, Oxman AO: Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992, 10:301-310.
23. Rodrigo C, Rodrigo G: Early administration of hydrocortisone in the emergency room treatment of acute asthma: a controlled clinical trial. Respir Med 1994, 88:755-761.
24. Kelly HW, Murphy S: Should anticholinergics be used in acute severe asthma? DICP Ann Pharmacother 1990, 24:409-416.
25. Bryant DH, Rogers P: Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma. Chest 1992, 102:742-747.
26. Cydulka RK, Emerman CL: Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma. Ann Emerg Med 1994, 23:270-274.
27. Rodrigo C, Rodrigo G: Treatment of acute asthma: lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer. Chest 1994, 106:1071-1076.
28. National Heart, Lung, and Blood Institute: National Asthma Education Program, Expert Panel Report: Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991, 88:425-433.
29. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign: Guidelines for management of asthma in adults: II. Acute severe asthma. BMJ 1990, 301:797-800.
30. Shaheen MJ, Ayres JG, Benincasa C: Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients. Eur Respir J 1994, 7:2160-2164. Suggests that the lecithin depressant in salmeterol might be responsible for the uncommon bronchospasm seen with this agent.
31. Haskell RJ, Wong BM, Hansen JE: A double-blind randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med 1983, 143:1324-1327.
32. Leung DYM, Szefler SJ: Steroid-resistant asthma. Med Sci Update 1995, 13:1-5. Good review on diagnosing and classifying steroid-resistant asthma.
33. Kamada AK, Spahn JD, Surs W, Brown E, Leung DYM, Szefler SJ: Clinical and laboratory observations: coexistence of glucocorticoid receptor and pharmacokinetic abnormalities. Factors that contribute to a poor response to treatment with glucocorticoids in children with asthma. J Pediatr 1994, 124:984-986.
34. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q: Dysregulation of interleukin 4, interleukin 5, and Interferon γ-gene expression in steroid-resistant asthma. J Exp Med 1995, 181:33-40.
35. Nassif EG, Weinberger M, Thompson R, Huntley W: The value of maintenance theophylline in steroid-dependent asthmatics. N Engl J Med 1981, 304:71-75.
36. Huang D, O'Brien RG, Harmon E, Aull L, Reents S, Visser J, Shieh G, Hendeles L: Does aminophylline provide benefit for adults hospitalized with an acute exacerbation of asthma? Ann Intern Med 1993, 119:1155-1160.
37. Aubier M, Barnes PJ: Theophylline and phosphodlesterase inhibitors. Eur Respir J 1995, 8:347-348. Updates data on theophylline and references recent studies just completed.
38. Peters JI: Emergency treatment of asthma. Curr Opin Pulm Med 1995, 1:65-72. Summarizes nonconventionai therapy.
39. Lockhart A, Slutsky AS: Furosemide and loop diuretics in human asthma. Chest 1994, 106:244-249.
40. Karpel JP, Dworkin F, Hager D, Feliciano S, Shapiro D, Posner L, Luks D: Inhaled furosemide is not effective in acute asthma. Chest 1994, 106:1396-1400.
41. van der Touw T, Tully A, Amis TC, Brancatisano A, Rynn M, Mudaliar Y, Engel LA: Cardiorespiratory consequences of expiratory chest wall compression during mechanical ventilation and severe hyperinflation. Crit Care Med 1993, 21:1908-1914.
42. Holgate ST: Antihistamines in the treatment of asthma. Clin Rev Allergy 1994, 12:65-78.
43. Shapiro MB, Kleaveland AC, Bartlett RH: Extracorporeal life support for status asthmaticus. Chest 1993, 103:1651-1654.
44. Manthous CA, Hall JB, Melmed A, Caputo MA, Walter J, Klocksieben JM, Schmidt GA, Wood LDH: Hellox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995, 151:310-314.
45. Kass JE, Castriotta J: Hellox therapy in acute severe asthma. Chest 1995, 107:757-760.
46. Ruegel W, Iber C, Davies S, Leatherman J: Risk factors for acute myopathy in patients with severe asthma who require mechanical ventilation [abstract]. Am J Respir Crit Care Med 1994, 149:A432.
47. American College of Chest Physicians Consensus Conference: Mechanical ventilation. Chest 1993, 194:1833-1859.